Yahoo

Amplifon (BIT:AMP) Stock May Be 34% Undervalued On Cash Flow

Amplifon has seen its share price fall sharply over recent years, which naturally raises a question for investors about whether the current market valuation still lines up with the cash flows the business is expected to generate. After a long slide and a few short-term rebounds, the key issue is how much of Amplifon's cash flow profile is already embedded in today's price.

  • Over the past 5 years the stock has declined 69.8%, putting the focus squarely on whether the share price now reflects the cash flows the business can realistically produce.

  • The group relies on converting hearing-care services and products into steady cash inflows, so the durability of customer demand and the investment needed to maintain its clinic network can meaningfully affect future cash generation for shareholders.

  • What if you looked at Amplifon through its earnings instead? See why Amplifon's 46.2x P/E tells a different valuation story .

The issue now is whether the current Amplifon share price is adequately supported by the cash flows implied by a Discounted Cash Flow (DCF) intrinsic value estimate.

If you are questioning whether Amplifon's current valuation lines up with its cash flows, it can help to compare that dilemma with other companies screened for 196 high quality undervalued stocks .

Is Amplifon Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) framework here projects what Amplifon might return to shareholders based on future free cash generation. Latest twelve month Free Cash Flow sits at about €285.9 million, so the model is treating Amplifon as a business that already produces meaningful cash and then layers on further growth over time.

Analysts feeding into this DCF expect free cash flows to rise in the coming years, with projections stepping up from current levels toward the low to mid €300 million range. Those estimates combine both external analyst inputs and mechanically extended forecasts, which means any change in Amplifon's reinvestment needs or hearing care demand could shift the outcome. When those projected cash streams are discounted back and compared with the current share price of €12.55, the DCF output suggests Amplifon's estimated intrinsic value sits substantially above where the stock trades today. Find out what Amplifon could be worth using our Discounted Cash Flow (DCF) estimate .

The Amplifon Narrative: What Would Justify Today's Price?

Narratives for Amplifon pick up where this valuation puzzle leaves off by spelling out which paths for growth, margins and earnings would need to play out for the stock to end up worth materially more or less than it is today on Simply Wall St's Community page. Each one treats Amplifon's implied fair value as a thesis that can be tracked over time rather than a static snapshot, so you can see how the story holds up as new information arrives.

Amplifon's community views split between a margin driven recovery story and a tougher read on digital and competitive risk.

Bull case: 8% undervalued

"The Fit4Growth program, which has already delivered around 70 to 90 bps of adjusted EBITDA margin improvement in H1 2026, is expected to keep supporting net margin and earnings…"

Discover why this Narrative puts Amplifon at 8% undervalued .

Bear case: 14% overvalued

"Rapid technological advancement and commoditization of hearing aid devices, particularly through the proliferation of over the counter products and smartphone enabled solutions, is increasingly eroding pricing power and diminishing the value proposition of specialized retailers…"

Explore why this Narrative puts Amplifon at 14% overvalued .

One more Amplifon check investors should not skip

Valuation only tells part of the story for Amplifon, since Simply Wall St's broader review has also flagged specific risk checks that investors may want to weigh before getting comfortable. Take a closer look at 4 warning signs before settling on a valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include AMP.MI .

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: